> Pall Life Sciences reports that third-quarter consumable sales to drugmakers grew 9 percent worldwide over third-quarter figures from a year ago, thanks in part to expanding adoption of single-use technologies. Item
> Contract manufacturer Patheon has expanded its services for Merck. Item
> Increased compliance requirements and pressure to achieve higher quality have resulted in new drug delivery options. Article
> ProximaRF and Phase IV Engineering have partnered to offer high-frequency RFID-enabled sensing products. Announcement
> Existing manufacturing facilities can be made smaller and more efficient by producing proteins in fermentors with Dyadic's C1 technology, a specialized fungus that can mass-produce enzymes and proteins. Article